An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.


NMRC Trains Sailors for CTC Influenza Study

BETHESDA, Md. (May 10, 2024) Hospital Corpsman 1st Class Adirachel Sauvou, from Naval Medical Research Command (NMRC), draws a blood samples as part of training for a flu prevention study. The study, an ongoing trial conducted by the NMRC Clinical Trials Center (CTC), evaluates the efficacy of SAb Biotherapeutics therapy SAB-176, a novel infectious disease therapy designated by the U.S. Food and Drug Administration. According to the Centers for Disease Control and Prevention, more than 14,000,000 medical visits, 360,000 hospitalizations and 21,000 deaths occurred in the United States due to influenza from 2022-2023. Influenza outbreaks can spread easily among active-duty service members, especially those living in congregate settings, reducing mission readiness. A prevention option that can be administered remotely could reduce disease burden and optimize health and operational readiness of Navy, Marine Corps and joint service personnel in all domains that may face a rapidly transmitted infectious disease threat. This study is open to all healthy active-duty military, dependents, retirees, WRNMMC personnel and other local individuals between the ages of 18 and 60. Participants must not be pregnant, cannot have received a flu shot in the past 90 days and must be able to complete at least eight visits to the CTC over the course of three months. Active-duty personnel will be required to complete a supervisor’s approval form. Participants may be eligible for compensation. If you would like to participate or have any questions, please contact the center at 301-233-9640 (text), or via e-mail at to schedule an appointment. The CTC, located at Naval Support Activity Bethesda, Building 17B (2nd floor), evaluates vaccines, therapeutics, prophylactics and medical devices in human subjects to advance products from the laboratory to the front line and maximize the medical readiness of the warfighter. (U.S. Navy photo by Sidney Hinds/Released)

VIRIN: 240510-N-KT630-1144.JPG
Photo by:
Download Image: Full Size

Photo Details

Resolution: 6720x4480
Size: 4.02 MB
Location: BETHESDA, MD

Guidance-Card-Icon Dept-Exclusive-Card-Icon